{
  "api_version": "1",
  "request": {
    "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=AS%2B&page=35",
    "query": {
      "intervention": "AS+",
      "page": 35
    },
    "page_size": 10
  },
  "pagination": {
    "page": 35,
    "page_size": 10,
    "total_count": 48438,
    "total_pages": 4844,
    "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=AS%2B&page=36&page_size=10",
    "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=AS%2B&page=34&page_size=10"
  },
  "source": "remote",
  "last_synced_at": "2026-10-31T16:18:09.979Z",
  "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.",
  "notes": [
    "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.",
    "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.",
    "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees."
  ],
  "trials": [
    {
      "nct_id": "NCT03408743",
      "title": "Engineering an Online STI Prevention Program: CSE2",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Alcohol Consumption",
        "Sexually Transmitted Diseases"
      ],
      "interventions": [
        {
          "name": "Knowledge Alone",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Self-efficacy alone",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Perceived benefits alone",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Benefits and self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Injunctive norms alone",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Injunctive norms and self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Injunctive norms and benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Injunctive norms, benefits, self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive norms alone",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive norms and self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive norms and perceived benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive norms, benefits, self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive norms and injunctive norms",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive and injunctive norms, self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive and injunctive norms, and benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive & injunctive norms, benefits, efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies alone",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies and self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies and perceived benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, benefits, self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies and injunctive norms",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, injunctive norms, self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, injunctive norms, and benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, injunctive norms, benefits, efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies and descriptive norms",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, descriptive norms, & self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, descriptive norms, benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, descriptive norms, benefits, efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, descriptive and injunctive norms",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, descriptive & injunctive norms, efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, descriptive & injunctive norms, benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, descriptive & injunctive, benefits, efficacy",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL"
      ],
      "sponsor": "Penn State University",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "30 Years",
        "sex": "ALL",
        "summary": "18 Years to 30 Years"
      },
      "enrollment_count": 2946,
      "start_date": "2017-09-18",
      "completion_date": "2017-12-31",
      "has_results": false,
      "last_update_posted_date": "2019-07-05",
      "last_synced_at": "2026-10-31T16:18:09.979Z",
      "location_count": 4,
      "location_summary": "Fresno, California • Fargo, North Dakota • Murfreesboro, Tennessee + 1 more",
      "locations": [
        {
          "city": "Fresno",
          "state": "California"
        },
        {
          "city": "Fargo",
          "state": "North Dakota"
        },
        {
          "city": "Murfreesboro",
          "state": "Tennessee"
        },
        {
          "city": "College Station",
          "state": "Texas"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT03408743"
    },
    {
      "nct_id": "NCT07070115",
      "title": "Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®",
      "overall_status": "RECRUITING",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Hiatal Hernia"
      ],
      "interventions": [
        {
          "name": "OviTex Reinforced Tissue Matrix",
          "type": "DEVICE"
        }
      ],
      "intervention_types": [
        "DEVICE"
      ],
      "sponsor": "Tela Bio Inc",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "22 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "22 Years and older"
      },
      "enrollment_count": 173,
      "start_date": "2025-07-25",
      "completion_date": "2032-07-31",
      "has_results": false,
      "last_update_posted_date": "2026-08-18",
      "last_synced_at": "2026-10-31T16:18:09.979Z",
      "location_count": 5,
      "location_summary": "Mobile, Alabama • Denver, Colorado • Lexington, Kentucky + 2 more",
      "locations": [
        {
          "city": "Mobile",
          "state": "Alabama"
        },
        {
          "city": "Denver",
          "state": "Colorado"
        },
        {
          "city": "Lexington",
          "state": "Kentucky"
        },
        {
          "city": "Charlotte",
          "state": "North Carolina"
        },
        {
          "city": "Austin",
          "state": "Texas"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT07070115"
    },
    {
      "nct_id": "NCT01021215",
      "title": "Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Tobacco Use Disorder"
      ],
      "interventions": [
        {
          "name": "Zileuton",
          "type": "DRUG"
        },
        {
          "name": "Celecoxib",
          "type": "DRUG"
        },
        {
          "name": "laboratory biomarker analysis",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "DRUG",
        "OTHER"
      ],
      "sponsor": "National Cancer Institute (NCI)",
      "sponsor_class": "NIH",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 84,
      "start_date": "2010-05",
      "completion_date": "2013-03",
      "has_results": true,
      "last_update_posted_date": "2015-04-02",
      "last_synced_at": "2026-10-31T16:18:09.979Z",
      "location_count": 2,
      "location_summary": "New York, New York • Houston, Texas",
      "locations": [
        {
          "city": "New York",
          "state": "New York"
        },
        {
          "city": "Houston",
          "state": "Texas"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01021215"
    },
    {
      "nct_id": "NCT01850108",
      "title": "Non-Myeloablative Conditioning and Bone Marrow Transplantation",
      "overall_status": "UNKNOWN",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Sickle Cell Disease",
        "Hemoglobinopathies"
      ],
      "interventions": [
        {
          "name": "Thymoglobulin",
          "type": "DRUG"
        },
        {
          "name": "Fludarabine",
          "type": "DRUG"
        },
        {
          "name": "Cyclophosphamide (CTX)",
          "type": "DRUG"
        },
        {
          "name": "Mesna",
          "type": "DRUG"
        },
        {
          "name": "Sirolimus",
          "type": "DRUG"
        },
        {
          "name": "Mycophenolate mofetil (MMF)",
          "type": "DRUG"
        },
        {
          "name": "Bone marrow transplantation",
          "type": "PROCEDURE"
        },
        {
          "name": "Total body irradiation",
          "type": "RADIATION"
        }
      ],
      "intervention_types": [
        "DRUG",
        "PROCEDURE",
        "RADIATION"
      ],
      "sponsor": "Vanderbilt-Ingram Cancer Center",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "1 Year",
        "maximum_age": "70 Years",
        "sex": "ALL",
        "summary": "1 Year to 70 Years"
      },
      "enrollment_count": 26,
      "start_date": "2013-05",
      "completion_date": "2024-12-31",
      "has_results": true,
      "last_update_posted_date": "2024-01-10",
      "last_synced_at": "2026-10-31T16:18:09.979Z",
      "location_count": 1,
      "location_summary": "Nashville, Tennessee",
      "locations": [
        {
          "city": "Nashville",
          "state": "Tennessee"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01850108"
    },
    {
      "nct_id": "NCT02461225",
      "title": "Study of Low Level Laser Therapy to Treat Diabetic Peripheral Neuropathy Foot Pain",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Diabetic Peripheral Neuropathy"
      ],
      "interventions": [
        {
          "name": "Erchonia® FX-635™",
          "type": "DEVICE"
        },
        {
          "name": "Placebo Laser",
          "type": "DEVICE"
        }
      ],
      "intervention_types": [
        "DEVICE"
      ],
      "sponsor": "Erchonia Corporation",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 30,
      "start_date": "2016-03-01",
      "completion_date": "2017-09-30",
      "has_results": true,
      "last_update_posted_date": "2022-03-15",
      "last_synced_at": "2026-10-31T16:18:09.979Z",
      "location_count": 1,
      "location_summary": "Mesa, Arizona",
      "locations": [
        {
          "city": "Mesa",
          "state": "Arizona"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT02461225"
    },
    {
      "nct_id": "NCT04338776",
      "title": "Comparing UroLift Experience Against Rezūm",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Benign Prostatic Hyperplasia"
      ],
      "interventions": [
        {
          "name": "UroLift",
          "type": "DEVICE"
        },
        {
          "name": "Rezum",
          "type": "DEVICE"
        }
      ],
      "intervention_types": [
        "DEVICE"
      ],
      "sponsor": "NeoTract, Inc.",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "50 Years",
        "maximum_age": null,
        "sex": "MALE",
        "summary": "50 Years and older · Male only"
      },
      "enrollment_count": 120,
      "start_date": "2021-01-22",
      "completion_date": "2025-12",
      "has_results": false,
      "last_update_posted_date": "2025-10-14",
      "last_synced_at": "2026-10-31T16:18:09.979Z",
      "location_count": 7,
      "location_summary": "Los Angeles, California • Royal Oak, Michigan • Garden City, New York + 4 more",
      "locations": [
        {
          "city": "Los Angeles",
          "state": "California"
        },
        {
          "city": "Royal Oak",
          "state": "Michigan"
        },
        {
          "city": "Garden City",
          "state": "New York"
        },
        {
          "city": "New York",
          "state": "New York"
        },
        {
          "city": "Austin",
          "state": "Texas"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT04338776"
    },
    {
      "nct_id": "NCT02427217",
      "title": "An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Congenital Fibrinogen Deficiency"
      ],
      "interventions": [
        {
          "name": "FCH",
          "type": "BIOLOGICAL"
        }
      ],
      "intervention_types": [
        "BIOLOGICAL"
      ],
      "sponsor": "CSL Behring",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": null,
        "maximum_age": null,
        "sex": "ALL",
        "summary": "Not listed"
      },
      "enrollment_count": 22,
      "start_date": "2015-05-07",
      "completion_date": "2017-12-06",
      "has_results": false,
      "last_update_posted_date": "2018-01-17",
      "last_synced_at": "2026-10-31T16:18:09.979Z",
      "location_count": 3,
      "location_summary": "Aurora, Colorado • Las Vegas, Nevada • Durham, North Carolina",
      "locations": [
        {
          "city": "Aurora",
          "state": "Colorado"
        },
        {
          "city": "Las Vegas",
          "state": "Nevada"
        },
        {
          "city": "Durham",
          "state": "North Carolina"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT02427217"
    },
    {
      "nct_id": "NCT04945317",
      "title": "ROSE for Improved Molecular Marker Testing Via EBUS",
      "overall_status": "ENROLLING_BY_INVITATION",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Non-small Cell Lung Cancer (NSCLC)"
      ],
      "interventions": [
        {
          "name": "ROSE (presence of cytotech) & liquid prep",
          "type": "OTHER"
        },
        {
          "name": "NO-ROSE (absence of cytotech) & liquid prep",
          "type": "OTHER"
        },
        {
          "name": "ROSE (presence of cytotech) & tissue clot sample",
          "type": "OTHER"
        },
        {
          "name": "NO-ROSE (absence of cytotech) & tissue clot sample",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "OTHER"
      ],
      "sponsor": "Johns Hopkins University",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 349,
      "start_date": "2021-05-14",
      "completion_date": "2026-12-31",
      "has_results": false,
      "last_update_posted_date": "2025-12-17",
      "last_synced_at": "2026-10-31T16:18:09.979Z",
      "location_count": 4,
      "location_summary": "Chicago, Illinois • Baltimore, Maryland • Charleston, South Carolina",
      "locations": [
        {
          "city": "Chicago",
          "state": "Illinois"
        },
        {
          "city": "Baltimore",
          "state": "Maryland"
        },
        {
          "city": "Baltimore",
          "state": "Maryland"
        },
        {
          "city": "Charleston",
          "state": "South Carolina"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT04945317"
    },
    {
      "nct_id": "NCT06941974",
      "title": "Partnering With Antenatal Navigators to Transform Health in Pregnancy",
      "overall_status": "RECRUITING",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Maternal Morbidity",
        "Antenatal Health",
        "Neonatal Morbidity",
        "Retention in Care",
        "Prenatal Care"
      ],
      "interventions": [
        {
          "name": "Patient Navigation Program",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL"
      ],
      "sponsor": "Northwestern University",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "16 Years",
        "maximum_age": "50 Years",
        "sex": "FEMALE",
        "summary": "16 Years to 50 Years · Female only"
      },
      "enrollment_count": 600,
      "start_date": "2025-10-06",
      "completion_date": "2030-06-01",
      "has_results": false,
      "last_update_posted_date": "2026-04-06",
      "last_synced_at": "2026-10-31T16:18:09.979Z",
      "location_count": 1,
      "location_summary": "Chicago, Illinois",
      "locations": [
        {
          "city": "Chicago",
          "state": "Illinois"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT06941974"
    },
    {
      "nct_id": "NCT01517074",
      "title": "Sirolimus Injections for Autoimmune Scleritis",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Scleritis"
      ],
      "interventions": [
        {
          "name": "Sirolimus",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "National Eye Institute (NEI)",
      "sponsor_class": "NIH",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 5,
      "start_date": "2012-01",
      "completion_date": "2014-04",
      "has_results": true,
      "last_update_posted_date": "2020-06-19",
      "last_synced_at": "2026-10-31T16:18:09.979Z",
      "location_count": 1,
      "location_summary": "Bethesda, Maryland",
      "locations": [
        {
          "city": "Bethesda",
          "state": "Maryland"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01517074"
    }
  ]
}